Jazz Pharmaceuticals Director Laura Hamill Disposes Shares for Tax Obligations
Jazz Pharmaceuticals plc
Subscribe to track JAZZ
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📊 Form 4 Filing Alert: Jazz Pharmaceuticals plc ($JAZZ) Insider: Hamill Laura (Director) Transaction Type: Tax Withholding (Code F) Shares Transacted: 1,706 ordinary shares Average Price: ~$241.41 Total Value: $411,848.78 Shares Held After: 6,832 Significance: Low (Mandatory tax withholding from RSU vesting)
Comprehensive Analysis
Insider Transaction Summary
Reporting Owner: Laura Hamill
Role: Director
Issuer: Jazz Pharmaceuticals plc (JAZZ)
Filing Date: September 2, 2026
Transaction Date: August 31, 2026
Transaction Breakdown
Laura Hamill reported two non-derivative dispositions of Ordinary Shares on August 31, 2026, executed under transaction code F:
-
Transaction 1: 14 Ordinary Shares disposed at $244.0643 per share.
-
Transaction 2: 1,692 Ordinary Shares disposed at $241.39 per share.
-
Total Shares Disposed: 1,706
-
Aggregate Consideration: ~$411,848.78
-
Remaining Direct Holdings: 6,832 Ordinary Shares
Context & Trading Significance
According to footnote disclosure [F1], the shares were surrendered/sold solely to satisfy tax withholding obligations triggered by the vesting of previously granted Restricted Stock Units (RSUs). Because these transactions are administrative, non-discretionary, and tied directly to routine equity compensation vesting schedules rather than open-market buying or selling decisions, the trading significance of this filing is categorized as Low.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.